Phio Pharmaceuticals CORP (PHIO) Institutional Ownership Tracker (Q2 2026)

PHIO ranks #7976 out of 37507 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

PHIO is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

24 institutions disclose a position in PHIO, but none treat it as a major bet — even Jane Street Group, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

PHIO reported a net loss of $12.9M over the trailing twelve months.

• Not yet profitable — net loss of $12.9M over the trailing twelve months
• Revenue declined 100.0% year over year
• Net income declined year over year, from -$7.1M to -$12.9M
• Operating cash flow was negative, using $8.0M in cash
• Liabilities run 0.07x equity — within a conventional range